Bagsværd, Denmark, 01 July 2015 - In continuation of the company''s announcements
dated 30 January 2015 and 30 April 2015 concerning planned share repurchase
programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed
Company Manual, this is to report that Novo Nordisk ...
↧